Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Introduction. Darunavir].
Clotet B. Clotet B. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 10:1-2. doi: 10.1016/s0213-005x(08)76546-7. Enferm Infecc Microbiol Clin. 2008. PMID: 19195452 Spanish. No abstract available.
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
Clotet B, Bellos N, Molina JM, Cooper D, Goffard JC, Lazzarin A, Wöhrmann A, Katlama C, Wilkin T, Haubrich R, Cohen C, Farthing C, Jayaweera D, Markowitz M, Ruane P, Spinosa-Guzman S, Lefebvre E; POWER 1 and 2 study groups. Clotet B, et al. Lancet. 2007 Apr 7;369(9568):1169-78. doi: 10.1016/S0140-6736(07)60497-8. Lancet. 2007. PMID: 17416261 Clinical Trial.
Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.
Moltó J, Santos JR, Pérez-Alvarez N, Cedeño S, Miranda C, Khoo S, Else L, Llibre JM, Valle M, Clotet B. Moltó J, et al. Among authors: clotet b. Antimicrob Agents Chemother. 2008 Nov;52(11):3928-32. doi: 10.1128/AAC.00520-08. Epub 2008 Aug 25. Antimicrob Agents Chemother. 2008. PMID: 18725446 Free PMC article.
[Pharmacological interactions with darunavir].
Moltó J, Valle M, Clotet B. Moltó J, et al. Among authors: clotet b. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 10:43-50. doi: 10.1016/s0213-005x(08)76553-4. Enferm Infecc Microbiol Clin. 2008. PMID: 19195459 Review. Spanish.
[Position of darunavir in antiretroviral therapy].
Clotet B. Clotet B. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 10:61-2. doi: 10.1016/s0213-005x(08)76555-8. Enferm Infecc Microbiol Clin. 2008. PMID: 19195461 Spanish. No abstract available.
[Etravirine: genetic barrier and resistance development].
Llibre JM, Santos JR, Clotet B. Llibre JM, et al. Among authors: clotet b. Enferm Infecc Microbiol Clin. 2009 Dec;27 Suppl 2:32-9. doi: 10.1016/S0213-005X(09)73217-3. Enferm Infecc Microbiol Clin. 2009. PMID: 20116626 Review. Spanish.
[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy].
Llibre JM, Antela A, Arribas JR, Domingo P, Gatell JM, López-Aldeguer J, Lozano F, Miralles C, Moltó J, Moreno S, Ortega E, Riera M, Rivero A, Villalonga C, Clotet B. Llibre JM, et al. Among authors: clotet b. Enferm Infecc Microbiol Clin. 2010 Nov;28(9):615-20. doi: 10.1016/j.eimc.2010.08.004. Enferm Infecc Microbiol Clin. 2010. PMID: 20888082 Review. Spanish.
1,146 results